News

AI for Drug Discovery Market Future Prospect 2028 with Leading Key Insight – Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc.

Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity.

The AI for drug discovery market is expected to grow during the forecast period due to the increasing number of cross-industry partnerships & collaborations, a significant growth in venture capital investments, rise in importance of drug discovery and increase in funding of the R&D activities for the use of AI technology in the field of drug discovery. However, limited awareness, unwillingness among medical practitioners to adopt AI-based technologies, unclear regulatory guidelines for medical software and lack of interoperability among AI solutions offered by different vendors are likely to hamper the growth of the market in the forecast period.

Request Sample Pages of this research study at – https://www.theinsightpartners.com/sample/TIPRE00004177/

The Prominent/Emerging Players in the AI for Drug Discovery Market Research include:

Atomwise, Inc.
Insilico Medicine
BIOAGE
Numerate
NuMedii, Inc.
Envisagenics
Cloud Pharmaceuticals, Inc.
BenevolentAI
twoXAR, Incorporated
Exscientia

The global AI for drug discovery market is segmented on the basis of drug type, technology, application, and end user. On the basis of drug type, the market is classified as small molecule and large molecules. Based on technology, the market is classified as deep learning and machine learning. Based on application, the market is classified as metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases, and others. On the basis of end user, the market is classified as pharmaceutical & biotechnological companies, academic & research institutes, and others.

Product Benchmarking:

Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.

Strategic Initiatives:

Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.

Order a copy of this research study at – https://www.theinsightpartners.com/buy/TIPRE00004177/

ABOUT US:

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact US:

If you have any queries about this report or would like further information, please contact us:

North America:+1 646 491 9876

Asia-Pacific:+91 20 6727 8686

Email: sales@theinsightpartners.com

Prashant Tambe
Prashant Tambe
An expert in SEO, Prashant carries an experience of over five years in the industry. He has the ability to analyze global industry trends that helps the leaders to make smarter decisions. An electrical, electronics and communication engineer, Prashant is able to predict future trends as they are changing fast with technological development.